PortalsOS

We do know now that if we catch the cancer early enough, even if you fail chemo, you fail radiation, brain tumors, we now have patients with brain tumors who have failed everything, come to see us. We're getting almost a complete response.

The FDA keeps telling you, no, no, no, not unless you do these trials. So I don't know in our lifetime, will we get... So are we going to avoid ovarian cancer? Are we going to avoid triple negative breast cancer? Are we going to avoid pancreatic cancer?

I'm getting calls for young ladies with triple negative breast cancer in their 30s. I'm getting calls for glioblastoma, which we have failed.

We've done this with healthy volunteers already. More importantly, the NCI then designated us to treat patients without cancer, i.e. patients with what we call Lynch syndrome.

We injected this in 8,000. And what kind of response rate have you seen from the people who do have a cancer? Metastatic pancreatic cancer. Patients now alive, still six years.

We have a trial now going on with long COVID where we're giving this BioShield for patients with long COVID. It's open.